This section of the HIPAA Privacy Rule may be used with the intention to design a research study or to assess the feasibility of conducting a study. Neither an authorization nor a waiver is required. (However, please note that although permitted under HIPAA, these activities are already required to be reviewed by the IRB.)
In addition to a detailed memo, the researcher must also submit a request to CPHS via the iRIS system that states:
The use or disclosure of PHI is solely to prepare a research protocol or for similar purposes preparatory to research
That the researcher will not remove any PHI from the covered entity, and
The PHI for which access is sought is necessary for the research purpose
In most instances, this type of research will still be reviewed under the guidelines for expedited review.
What is a Covered Entity?
HIPAA defines a Covered Entity as a:
Health Plan
Health Care Provider - specifically a provider who conducts certain financial and administrative transactions electronically (e.g., billing, funds transfer, insurance claims)
Health Care Clearing House - an organization that processes or facilitates the processing of health information in non-standard format to standard format or vice versa (e.g., a physician's billing service).
For other questions, please call us at 713-500-7943.